AMOYTOP(688278.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
AMOYTOP
688278.SH
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd.
1.468 T
688278.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
A
BiotechnologyIndustry
Industry Ranking2/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE31.78%A
    • Profit Margin26.53%A
    • Gross Margin89.45%A
  • Growth ScoreA
    • Revenue YoY29.70%A
    • Net Profit YoY15.06%C
    • Total Assets YoY40.40%A
    • Net Assets YoY32.05%A
  • Cash ScoreB
    • Cash Flow Margin64.82%C
    • OCF YoY29.70%A
  • Operating ScoreA
    • Turnover1A
  • Debt ScoreA
    • Gearing Ratio18.66%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Aligos 10-K: Revenue $2.19M, EPS (2.45) — 2025 Annual Filing

    TradingView·
    US
    VHT
    +0.97%
    US
    XLV
    +1.10%
    US
    ARKG
    +0.04%
    TradingView·
    US
    VHT
    +0.97%
    US
    XLV
    +1.10%
    US
    ARKG
    +0.04%

    Asian Value Stock Picks For Intrinsic Valuation Estimates January 2026

    Simplywall·
    SH
    688278
    -0.62%
    SZ
    002466
    +2.37%
    HK
    09696
    +2.96%
    Simplywall·
    SH
    688278
    -0.62%
    SZ
    002466
    +2.37%
    HK
    09696
    +2.96%

    3 Asian Stocks Estimated To Be 35.9% To 49.2% Below Intrinsic Value

    Simplywall·
    US
    SSNGY
    0.00%
    SH
    688278
    -0.62%
    Simplywall·
    US
    SSNGY
    0.00%
    SH
    688278
    -0.62%

    3 Asian Stocks Estimated To Be Undervalued In January 2026

    Simplywall·
    SH
    688278
    -0.62%
    SH
    600166
    -1.55%
    Simplywall·
    SH
    688278
    -0.62%
    SH
    600166
    -1.55%

    Asian Market Stocks Estimated Up To 26% Below Intrinsic Value

    Simplywall·
    SH
    601567
    -1.63%
    SZ
    301589
    +0.85%
    SH
    688278
    -0.62%
    Simplywall·
    SH
    601567
    -1.63%
    SZ
    301589
    +0.85%
    SH
    688278
    -0.62%
    © 2026 Longbridge｜Disclaimer